Abcellera Biologics Inc (NQ: ABCL )

2.495 +0.015 (+0.60%)

Streaming Delayed Price Updated: 12:13 PM EDT, Sep 24, 2024 Add to My Watchlist

Price and Volume

Volume	651,122
Open	2.480
Bid (Size)	2.490 (53)
Ask (Size)	2.500 (40)
Prev. Close	2.480
Today's Range	2.460 - 2.550
52wk Range	2.335 - 6.055
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week

September 15, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual...

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th

September 10, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 and should result in as many as 50 novel therapies being brought to market by then and generate annual...

Via Talk Markets

Performance

YTD	-56.46%	-56.46%
1 Month	-7.25%	-7.25%
3 Month	-10.57%	-10.57%
6 Month	-45.52%	-45.52%
1 Year	-47.69%	-47.69%

More News

Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!

September 05, 2024

Via Talk Markets

AbCellera to Present at Upcoming Investor Conferences in September

August 29, 2024

From AbCellera Biologics Inc.

Via Business Wire

Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week

August 27, 2024

Via Talk Markets

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

August 20, 2024

Via Benzinga

AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD

August 14, 2024

Via Talk Markets

AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript

August 07, 2024

Via The Motley Fool

AbCellera Reports Q2 2024 Business Results

August 06, 2024

From AbCellera Biologics Inc.

Via Business Wire

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

July 31, 2024

From AbCellera Biologics Inc.

Via Business Wire

AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD

July 30, 2024

Via Talk Markets

"Bubble" In AI/Semiconductor Stocks Began To Re-Inflate On Friday

July 28, 2024

Via Talk Markets

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

July 21, 2024

Via The Motley Fool

AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD

July 18, 2024

Via Talk Markets

Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD

July 14, 2024

Via Talk Markets

3 Biotech Stocks That Can Gain Exponentially By Leveraging AI

July 02, 2024

Via Talk Markets

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

June 25, 2024

From AbCellera Biologics Inc.

Via Business Wire

Largest Clinical-Stage BioTech Drug Stocks Declined 6%

June 22, 2024

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th

June 17, 2024

Via Talk Markets

Down 57%, Is AbCellera Biologics a Buy on the Dip?

June 13, 2024

Via The Motley Fool

AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week

June 10, 2024

Via Talk Markets

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 28, 2024

From AbCellera Biologics Inc.

Via Business Wire

Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week

May 27, 2024

Via Talk Markets

A $50B AI Drug Discovery Revolution Has Begun - Here Are 6 Stocks To Consider Investing In

May 20, 2024

Via Talk Markets

Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week

May 13, 2024

Via Talk Markets

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.